Improving Health-Promoting Behaviors in Adolescent Cancer Survivors Using AWAKE: A Feasibility Trial
CHOA AWAKE
1 other identifier
interventional
92
1 country
1
Brief Summary
A behavioral intervention called Achieving Wellness After Kancer in Early Life (AWAKE) focused on increasing hope in order to improve quality of life and health-promoting behaviors in survivors of young adult cancer. The goals of this project are to adapt the AWAKE platform into an intervention acceptable for use in adolescent cancer survivors and their guardians in order to improve survivors' hope, quality of life, and health-promoting behaviors, and to generate the preliminary data needed for a randomized control trial to test the efficacy of the AWAKE platform in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2018
CompletedStudy Start
First participant enrolled
June 20, 2018
CompletedFirst Posted
Study publicly available on registry
June 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2020
CompletedDecember 8, 2021
December 1, 2021
2.2 years
June 11, 2018
December 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the he Children's Hope Scale score
A 6-item self-report questionnaire assessing children's dispositional hope. Two components, agency (ability to initiate and sustain action towards goals) and pathways (capacity to find a means to carry out goals), are assessed by the measure. Responses are on a 6-point Likert-scale ranging from 1=none of the time to 6=all of the time with higher scores representing increased dispositional hope.
Baseline, 2 and 4 months follow up visits
Secondary Outcomes (7)
Change in the Pediatric Quality of Life Inventory (PedsQL), 4.0 scale score
Baseline, 2 and 4 months follow up visits
Change in number of servings of fruits and vegetables
Baseline, 2 and 4 months follow up visits
Change in number of physical activity hours per day
Baseline, 2 and 4 months follow up visits
Change in number of screen time hours per day
Baseline, 2 and 4 months follow up visits
Change in PROMIS score
Baseline, 2 and 4 months follow up visits
- +2 more secondary outcomes
Study Arms (2)
AWAKE
EXPERIMENTALThe AWAKE intervention is an 8 week program including a mobile app and phone-based coaching, focused on improving hope in order to increase quality of life and health-promoting behaviors in young adult cancer survivors.
No treatment
NO INTERVENTIONControl participants will receive the surveys to complete only; however, they may opt to receive the intervention after the 4-month assessment.
Interventions
Behavioral intervention called Achieving Wellness After Kancer in Early Life (AWAKE) is focused on increasing hope in order to improve quality of life and health-promoting behaviors in survivors of young adult cancer. The AWAKE mobile app contains eight modules for participants to complete over 8 weeks with the ability to review prior modules. Participants receive a prompt on their mobile device weekly to complete each module and/or they will receive a text reminder. The app includes health education messaging, weekly homework assignments, the ability to track progress towards goals with self-monitoring and graphical depictions of progress, videos of inspirational materials, and a portal for interacting with their coach.
Eligibility Criteria
You may qualify if:
- Adolescent survivors:
- Early survivor: 3 months to 2 years after therapy completion
- Long-term survivor: ≥2 years after therapy completion
- years of age
- Access to tablet or smartphone and internet
- One designated guardian per survivor
You may not qualify if:
- Cognitive delay that would preclude participation
- Participant or designated guardian unable to read English
- Active disease relapse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (1)
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Effinger, MD, MS
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 11, 2018
First Posted
June 21, 2018
Study Start
June 20, 2018
Primary Completion
September 15, 2020
Study Completion
September 15, 2020
Last Updated
December 8, 2021
Record last verified: 2021-12